Harmonizing PD-L1 testing in metastatic triple negative breast cancer. Read more about Harmonizing PD-L1 testing in metastatic triple negative breast cancer.
Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer. Read more about Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer.
Promise of gene therapy to treat sickle cell disease. Read more about Promise of gene therapy to treat sickle cell disease.
Cellular immunotherapy for malignant gliomas. Read more about Cellular immunotherapy for malignant gliomas.
Prospects for the use of ipilimumab in treating advanced prostate cancer. Read more about Prospects for the use of ipilimumab in treating advanced prostate cancer.
Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma. Read more about Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma.
Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge). Read more about Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge).
The prevention and management of stroke in sickle cell anaemia. Read more about The prevention and management of stroke in sickle cell anaemia.
STAT3 as a therapeutic target in head and neck cancer. Read more about STAT3 as a therapeutic target in head and neck cancer.
Cytokine gene therapy for malignant glioma. Read more about Cytokine gene therapy for malignant glioma.